Clinical Trial

Harlem Strong Mental Health Coalition

Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated May 20, 2026 (before its estimated June 30, 2026 completion). Its status may not reflect the trial's current state.
Summary
Addressing health disparities, especially in the face of coronavirus pandemic, requires an integrated multi-sector equity-focused, community-based approach. This study will examine the impact of Harlem Strong Community Mental Health Collaborative, a community-wide multi-sectoral coalition in which a health insurer works with a network of community-based organizations, medical providers, and behavioral health providers to engage in a network-wide implementation planning process to: (1) problem-solve financing, access, and quality of care barriers, (2) support capacity building for mental health (MH) task-sharing for community health workers, (3) facilitate coordination and collaboration across MH/behavioral health, primary care, and a range of social services, including case management, housing supports, financial education, employment support, and other community resources to improve linkages to services, and (4) identify a set of common MH, social risk, and health metrics and strategies to integrate these metrics into data systems across the network for continuous quality improvement of the system. The long-term goal of our study is to develop sustainable model for task-sharing MH care that will be embedded in a coordinated comprehensive network of services, including primary care, behavioral/MH, social services, and other community resources.
Protocol Amendment History 4 amendments
This ClinicalTrials.gov record has been amended 4 times since 2023-04-17; most recent amendment 2026-05-18.
Trial Details
NCT Number NCT05833555
Lead Sponsor City University of New York, School of Public Health
Collaborators: Harlem Congregation for Community Improvement, Inc., Healthfirst
Conditions Stress-related Problem, Depression, Anxiety, Mental Health Wellness
Enrollment 700 participants
Start Date 2023-04-05
Primary Completion 2026-06-30 (estimated)
Study Completion 2026-08-31 (estimated)
Updated on ClinicalTrials.gov 2026-05-20